DreaMed Advisor Pro vs WAVE Clinical Platform

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by DreaMed Diabetes
VS
by Excel Medical Electronics

AI Verdict

DreaMed Advisor Pro is specifically designed for personalized diabetes management, leveraging AI to optimize insulin pump settings and provide tailored tips for patients with Type 1 and Type 2 diabetes. In contrast, the WAVE Clinical Platform is a broader patient surveillance system focused on predicting general patient deterioration through continuous monitoring and predictive analytics. While both are FDA-cleared, AI-powered clinical decision support tools, they address distinct clinical problems and target different patient populations.

Choose DreaMed Advisor Pro if…

Choose DreaMed Advisor Pro if your clinical practice focuses on optimizing insulin therapy and providing personalized management for patients with Type 1 or Type 2 diabetes. This tool is ideal for healthcare professionals seeking AI-driven recommendations to fine-tune insulin pump settings and deliver tailored advice based on comprehensive glucose and insulin data. It excels in supporting long-term chronic disease management and improving glycemic control.

View DreaMed Advisor Pro →

Choose WAVE Clinical Platform if…

Choose WAVE Clinical Platform if your primary need is proactive patient surveillance and early detection of deterioration in an acute care environment. This system is best suited for hospitals and critical care units that that require continuous, real-time physiological monitoring and predictive analytics to identify at-risk patients hours before a critical event. It enhances patient safety by integrating with existing EMRs and providing mobile alerts for timely clinical intervention.

View WAVE Clinical Platform →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature DreaMed Advisor Pro WAVE Clinical Platform
Pricing Not publicly disclosed Contact for pricing
Deployment Cloud-based SaaS Software platform, leverages existing hospital IT infrastructure, client-server architecture, web-enabled devices.
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DreaMed Advisor Pro

DreaMed Advisor Pro is a cloud-based SaaS solution designed to simplify insulin dosing, with studies indicating high user-friendliness and time-saving benefits for endocrinologists. Its patient app further enhances accessibility. While WAVE Clinical Platform offers mobile compatibility and real-time data, its deep integration into complex hospital IT infrastructure may imply a more involved setup and learning curve for its comprehensive features.

Clinical Value

WAVE Clinical Platform

Both tools offer significant, FDA-cleared clinical value in their respective domains. However, WAVE Clinical Platform's ability to provide early warning of patient deterioration up to six hours in advance and its demonstrated impact on reducing unexpected hospital deaths (from six to zero in a UPMC trial) represents a broader and potentially more critical life-saving clinical impact across various acute care settings. DreaMed Advisor Pro, while effective in diabetes management, focuses on a more specialized area.

Pricing & Value

Tie

Neither DreaMed Advisor Pro nor WAVE Clinical Platform publicly discloses its pricing information. Without transparent pricing details, it is impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value for money. Both products offer substantial clinical benefits, but a definitive winner in this dimension cannot be determined.

Enterprise Readiness

WAVE Clinical Platform

WAVE Clinical Platform demonstrates stronger enterprise readiness through its explicit deep integration with major EMR solutions and existing hospital IT infrastructure, including a partnership with Epic Systems. Its design for comprehensive patient surveillance across hospital workstations and mobile devices, along with customizable alarm management, highlights its robust capabilities for large-scale healthcare environments. DreaMed Advisor Pro, while cloud-based and HIPAA compliant, has its broader EMR integration capabilities still under evaluation.

Innovation

WAVE Clinical Platform

Both tools showcase significant innovation. However, WAVE Clinical Platform stands out as the 'first FDA-cleared AI patient surveillance system' for predicting patient deterioration up to six hours in advance, with proven results in preventing unexpected deaths. This represents a groundbreaking application of AI in critical care with a broad impact on patient safety. DreaMed Advisor Pro's adaptive learning for personalized insulin optimization is also innovative but more niche.

Support & Docs

DreaMed Advisor Pro

DreaMed Advisor Pro explicitly outlines its support structure, including contact information for DreaMed Diabetes support, a process for reporting issues through Diabetes Management Systems, and the availability of user manuals and required training. In contrast, the provided information for WAVE Clinical Platform lacks specific details regarding its customer support channels, technical documentation, or training requirements, making Tool A appear more transparent in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature DreaMed Advisor Pro WAVE Clinical Platform
Name DreaMed Advisor Pro WAVE Clinical Platform
Company DreaMed Diabetes Excel Medical Electronics
Description DreaMed Advisor Pro is an FDA-cleared AI-based clinical decision support software that helps healthcare professionals optimize insulin pump settings and provide personalized diabetes management tips for patients with Type 1 and Type 2 diabetes. The WAVE Clinical Platform by Excel Medical Electronics is the first FDA-cleared AI patient surveillance system that uses predictive algorithms to provide early warning of patient deterioration, integrating with EMRs and mobile devices to enhance clinical decision support and patient safety.
Key Features AI-based insulin delivery recommendations, Analyzes CGM, SMBG, and insulin pump data, Optimizes insulin pump settings (basal rate, carb ratio, correction factor), Provides personalized diabetes management tips, Cloud-based platform, Recommendations reviewed and approved by healthcare professional, Supports Type 1 and Type 2 diabetes, Supports insulin pump therapy and multiple daily injections (MDI) Always-on remote patient monitoring, Near real-time display of physiologic data, waveforms, and alarms, Predictive analytics for patient deterioration (e.g., Visensia Safety Index), Early warning of patient deterioration (up to 6 hours in advance), Integration with Electronic Medical Records (EMR), Mobile device compatibility for alerts and data display, Customizable alarm management and routing (AlarmNavigator), Risk stratification of patients
Specialties Endocrinology, Family Medicine, Internal Medicine Critical Care, Emergency Medicine, Hospital Medicine

Videos

Demos, reviews, and walkthroughs featuring DreaMed Advisor Pro and WAVE Clinical Platform.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

DreaMed Advisor Pro is an AI-based clinical decision support software focused on optimizing insulin pump settings and providing personalized diabetes management tips for patients with Type 1 and Type 2 diabetes. In contrast, the WAVE Clinical Platform is an AI patient surveillance system designed to provide early warning of patient deterioration for a broader range of hospitalized patients, enhancing overall patient safety.
DreaMed Advisor Pro analyzes Continuous Glucose Monitoring (CGM), Self-Monitoring Blood Glucose (SMBG), and insulin pump data to generate its recommendations. The WAVE Clinical Platform integrates with Electronic Medical Records (EMRs) and utilizes near real-time physiologic data, waveforms, and alarms for its predictive analytics.
DreaMed Advisor Pro provides AI-based insulin delivery recommendations, optimizing insulin pump settings such as basal rate, carb ratio, and correction factor, along with personalized diabetes management tips. The WAVE Clinical Platform offers predictive analytics, like the Visensia Safety Index, to provide early warnings of patient deterioration up to 6 hours in advance, and supports risk stratification of patients.
DreaMed Advisor Pro supports both insulin pump therapy and multiple daily injections (MDI) for diabetes management. The WAVE Clinical Platform focuses on always-on remote patient monitoring, displaying near real-time physiologic data, waveforms, and alarms to predict patient deterioration.
AI Tool Finder
AI-powered search. Results may not be comprehensive.